Bicycle Therapeutics (BCYC) Profit After Tax: 2018-2025

Historic Profit After Tax for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to -$59.1 million.

  • Bicycle Therapeutics' Profit After Tax fell 16.33% to -$59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$250.7 million, marking a year-over-year decrease of 50.79%. This contributed to the annual value of -$169.0 million for FY2024, which is 6.46% up from last year.
  • Bicycle Therapeutics' Profit After Tax amounted to -$59.1 million in Q3 2025, which was up 25.19% from -$79.0 million recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Profit After Tax high stood at -$14.7 million for Q3 2021, and its period low was -$79.0 million during Q2 2025.
  • Its 3-year average for Profit After Tax is -$49.9 million, with a median of -$49.9 million in 2023.
  • Per our database at Business Quant, Bicycle Therapeutics' Profit After Tax surged by 32.06% in 2024 and then tumbled by 128.89% in 2025.
  • Bicycle Therapeutics' Profit After Tax (Quarterly) stood at -$18.0 million in 2021, then plummeted by 66.37% to -$30.0 million in 2022, then slumped by 63.79% to -$49.1 million in 2023, then fell by 5.56% to -$51.8 million in 2024, then dropped by 16.33% to -$59.1 million in 2025.
  • Its Profit After Tax stands at -$59.1 million for Q3 2025, versus -$79.0 million for Q2 2025 and -$60.8 million for Q1 2025.